FR Doc E8-3173 [Federal Register: February 21, 2008 (Volume
73, Number 35)] [Notices] [Page 9590] From the Federal Register
Online via GPO Access [wais.access.gpo.gov] [DOCID:fr21fe08-90]
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances; Notice of Registration
By notice dated October 31, 2007 and published in the Federal
Register on November 7, 2007, (72 FR 62872), Hospira, Inc., 1776
North Centennial Drive, McPherson, Kansas 67460-1247, made
application by renewal to the Drug Enforcement Administration (DEA)
to be registered as an importer of Remifentanil (9739), a basic
class of controlled substance listed in schedule II.
The company plans to import Remifentanil for use in dosage
form manufacturing.
No comments or objections have been received. DEA has
considered the factors in 21
U.S.C. 823(a) and 952(a)
and determined that the registration of Hospira, Inc. to import
the basic class of controlled substance is consistent with the
public interest and with United States obligations under
international treaties, conventions, or protocols in effect on
May 1, 1971, at this time. DEA has investigated Hospira, Inc. to
ensure that the company's registration is consistent with the
public interest. The investigation has included inspection and
testing of the company's physical security systems, verification
of the company's compliance with state and local laws, and a
review of the company's background and history. Therefore,
pursuant to 21 U.S.C. 952(a) and 958(a), and in accordance with 21
CFR 1301.34, the above named company is granted registration
as an importer of the basic class of controlled substance
listed.
Dated: February 12, 2008.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion
Control, Drug Enforcement Administration.
[FR Doc. E8-3173 Filed 2-20-08; 8:45 am]
BILLING CODE 4410-09-P
NOTICE: This is an
unofficial version. An official version of these publications may be obtained
directly from the Government Printing Office (GPO).